SUSTAINED-ACTION AMPHETAMINE-MEPROBAMATE COMBINATION FOR THE TREATMENT OF OBESITY.
D000661:Amphetamine; D000662:Amphetamines; D001067:Appetite Depressants; D035843:Biomedical Research; D003692:Delayed-Action Preparations; D003863:Depression; D003866:Depressive Disorder; D004358:Drug Therapy; D004485:Eczema; D004890:Erythema; D008620:Meprobamate; D009765:Obesity; D010600:Pharmacology; D012472:Salivation; D007319:Sleep Initiation and Maintenance Disorders; D014116:Toxicology
D000662:Amphetamines; D001067:Appetite Depressants; D003692:Delayed-Action Preparations; D008620:Meprobamate; D000661:Amphetamine
AMPHETAMINE; APPETITE DEPRESSANTS; CLINICAL RESEARCH; DELAYED-ACTION PREPARATIONS; DEPRESSION; DRUG THERAPY; ECZEMA; ERYTHEMA; INSOMNIA; MEPROBAMATE; PHARMACOLOGY; SALIVATION; TOXICOLOGIC REPORT